Cancer systems immunology

santiago_carmona-7225.jpg (Santigo Carmona - DO CHUV Unil)

Santiago CARMONA
Group Leader, SNF Ambizione Fellow
Laboratory S. Carmona
(hosted by Laboratory G. Coukos)

Department of oncology UNIL CHUV
Ludwig Institute for Cancer Research Lausanne

Phone +41 21 692 58 92
Email Santiago.carmona@unil.ch

Ludwig.jpg (Print)

 

 

Research interest

Our laboratory develops novel computational methods and single-cell data-driven models to understand immunity in cancer and infection.

Research group projects

A meta-analysis of T-cell states in cancer

Multiple signals affect T cell differentiation and function in cancer, giving rise to T cell states that differ from those generated upon acute infections. In recent years, single-cell transcriptomics have revealed a large diversity of tumor-infiltrating T lymphocyte (TIL) states, some of which appear to be associated with improved prognosis or response to immune checkpoint blockade. Because of the variability between individuals and tissues, there are major computational challenges associated to data integration and the delineation of discrete cell states. Moreover, it remains unclear to what extent T cells states are conserved between humans and mice. As a consequence, a robust definition of T cell states across studies, tumor models, tissues and organisms is still lacking.

The goal of this project is to generate curated, multi-species cell atlases that accurately describe transcriptional, epigenetic and metabolic states of T cells in health and disease.

Interpretation of immune responses by computational modeling of single T-cell transcriptomes

While the pace of scRNA-seq data generation is rapidly increasing, the lack of reference frameworks to compare experiments and experimental conditions imposes important limitations on the biological interpretation of the data. The objective of this project is to develop computational methods for the analysis of single-cell transcriptomics data in the context of reference cell atlases, and in this way aid the interpretation of in vivo immunological states using robust and reproducible computational pipelines.

DO SC research project fig1s.png

A Tumor scRNA-seq following experimental therapy. B Projection of query data onto a reference TIL atlas using ProjecTILs. C Description of T cell state novelty in terms of reference gene programs.

Determining T cell differentiation pathways in cancer and chronic infection by spatio-temporal analysis of transcriptional programs and clonotypes

Multi-modal single T-cell data including transcriptome, chromatin accessibility, T cell receptor and antigen specificity open unprecedented opportunities to explore the interplay between transcriptional and epigenetic programs, T cell affinity and clonotype.

The aim of this project is to generate multi-modal multi-tissue time-course single-T cell data and develop computational frameworks to exploit them to reconstruct T cell differentiation pathways, identify master gene regulators and learn the molecular rules that determine fate decisions in cancer and chronic infection. In collaboration with our experimental partners, we use CRISPR/Cas9 to target candidate gene regulators and reprogram T cell fate in vivo.

Prediction of tumor-reactive T cell receptors for personalized adoptive cell cancer therapy by computational modeling of T cell differentiation states

A promising approach to treat solid tumors consists of adoptive transfer of genetically modified T cells with enhanced functionality and bearing neoantigen-specific transgenic antigen receptors. However, identification of potent anti-tumor T cell receptors remains a major challenge.

This project aims to develop data-driven solutions for epitope-agnostic discovery of high-affinity anti-tumor TCRs using scRNA-seq of patients’ biopsies of tumors, lymph nodes or peripheral blood, for their use in next-generation adoptive T cell cancer therapies.

DO SC research project fig2.png

Discover the Lab code repository

Follow the Lab on Twitter

Selected publications

  1. Massimo Andreatta and Santiago J Carmona*. STACAS: Sub-Type Anchor Correction for Alignment in Seurat to integrate single-cell RNA-seq data. Bioinformatics (2020)
  2. Santiago J. Carmona*, Imran Siddiqui, Mariia Bilous, Werner Held, David Gfeller*. Deciphering the transcriptomic landscape of tumor-infiltrating CD8 lymphocytes in B16 melanoma tumors with single-cell RNA-Seq. OncoImmunology (2020)
  3. Amaia Martinez-Usatorre, Santiago J. Carmona, Céline Godfroid, Céline Yacoub Maroun, Sara Labiano and Pedro Romero. Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells. Frontiers in Immunology (2020)
  4. Siddiqui I et al. Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy. Immunity (2019)
  5. Santiago J Carmona, Sarah A Teichmann, Lauren Ferreira, Iain C Macaulay, Michael J.T. Stubbington, Ana Cvejic, David Gfeller. Single-cell transcriptome analysis of fish immune cells provides insight into the evolution of vertebrate immune cell types. Genome Research (2017) 27 (3), 451-461 

Discover the complete listing of Santiago Carmona's publications on ORCID and Google Scholar.

Funding

  • 2019-2023 Swiss National Science Foundation (SNSF) Ambizione Grant (#PZ00P3_180010)

Group members

Ch. des Boveresses 155 - CH-1066 Epalinges
Switzerland
Tel. +41 21 692 59 92
Fax +41 21 692 59 95
ludwig_cancer_research-logo.svg universite_de_lausanne-logo.svg chuv-logo.svg